Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis

BACKGROUND: The purpose of this comprehensive meta-analysis was to assess the association of aldehyde dehydrogenase (ALDH) expression with overall survival (OS) and disease-free survival (DFS)/progression-free survival (PFS) in ovarian cancer patients. METHODS: Systematic searches of Pubmed database...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yan, Wei, Xuemin, Gong, Hui, Ni, Yunxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284301/
https://www.ncbi.nlm.nih.gov/pubmed/30522488
http://dx.doi.org/10.1186/s12905-018-0686-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284301/
https://www.ncbi.nlm.nih.gov/pubmed/30522488
http://dx.doi.org/10.1186/s12905-018-0686-x

Ejemplares similares